{"type":"PR","pr":{"number":375,"head":"727352c305ee9f4b6a1b8a595b00e52bd25c0d68"},"user":"silvia.vernotico","status":"draft","branch":"cms/2019-08-22-hot-this-week-in-farmaceutica-younger-n-115","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.115","description":"La Food and Drug Administration statunitense ha approvato Xenleta (lefamulina), un antibiotico orale e endovenoso per il trattamento di adulti con polmonite batterica acquisita in comunit√† (CABP, community-acquired bacterial pneumonia).","objects":{"entry":{"path":"site/content/hotthisweek/2019-08-22-hot-this-week-in-farmaceutica-younger-n-115.md","sha":"250151ffdd2b7de76f6036d473a47eb3c6de8bc8"},"files":[]},"timeStamp":"2019-08-22T14:15:24.479Z"}